期刊文献+

腹膜透析患者腹腔白细胞介素6水平对腹膜溶质转运功能的影响 被引量:9

Impact of dialysate interleukin-6 level on the alteration of peritoneal solute transport rate in peritoneal dialysis patients
原文传递
导出
摘要 目的探讨腹膜透析(腹透)患者腹腔白细胞介素6(IL-6)水平对腹膜溶质转运功能的影响。方法人选稳定持续非卧床腹膜透析(CAPD)患者128例,采用ELISA法测定腹透透出液IL-6的浓度,计算IL-6呈现率(appearancerate,AR),前瞻性观察患者肌酐溶质转运面积系数(masstransferareacoefficientofcreatinine,MTACcr)的变化。采用Logistic回归分析透出液IL-6AR对患者腹膜溶质转运功能改变的影响。结果人选患者的基线MTACcr中位数Ⅲ(1,4,3,4)]水平为6.40(4.70,8.75)ml/min,12个月后MTACcr[7.14(5.59,8.73)ml/min]较基线期明显升高(P〈0.05)。与腹膜溶质转运功能稳定组相比,溶质转运功能增高组患者腹透透出液IL-6AR明显升高277.08(247.45,349.53)pg/min比263.18(69.94,286.72)pg/min,P〈0.05],残肾功能较低[0.79(0,2.12)mFmin比1.70(0.39,3.38)ml/min,P〈0.05],尿量减少[225(0,600)ml/24h比500(125,900)ml/24h,P〈0.05],患者基线MTACcr较低[5148(4.17,7.42)ml/min比7.00(5.46,9.76)mYmin,P〈0.05]。Logistic回归分析结果显示高透出液IL-6AR和低基线MTACcr是影响腹膜溶质转运功能远期改变的独立危险因素(均P〈0.05)。结论腹腔局部炎性反应影响腹膜溶质转运功能的改变,腹腔IL.6水平是预测腹膜溶质转运功能改变的独立危险因素。 Objective To evaluate the effect of dialysate interleukin-6 (IL-6), a marker of ongoing peritoneal inflammation, on the alteration of peritoneal solute transport rates (PSTRs) in stable continuous ambulatory peritoneal dialysis (CAPD) patients. Methods A total of 128 case of stable CAPD patients were enrolled in present study. IL-6 levels in the overnight effluent were determined by ELISA and IL-6 appearance rates (AR) were calculated. Mass transfer area coefficients of creatinine (MTACcr) were prospectively followed up. Logistic regression was used to examine the association between IL-6 AR and increased PSTRs. Results The MTACcr was significantly increased after 12 months follow- up [M(1/4, 3/4), 6.40(4.70, 8.75) ml/min vs 7.14(5.59, 8.73) ml/min, P〈 0.05]. Compared to the patients with stable PSTRs, the dialysate IL-6 AR in patients with increased PSTRs showed significantly higher [277.08(247.45, 349.53) pg/min vs 263.18 (69.94, 286.72) pg/min, P 〈 0.05]. Patients with increased PSTRs also had lower residual renal function [0.79(0, 2.12) ml/min vs 1.70 (0.39, 3.38) ml/min, P 〈 0.05], less urine volume [225(0, 600) ml/24 h vs 500(125, 900) ml/24 h, P 〈 0.05] and lower baseline MTACcr [5.48 (4.17, 7.42) ml/min vs 7.00(5.46, 9.76) ml/min, P 〈 0.05] when compared to their counterparts with stable PSTRs. Logistic analysis showed that high dialysate IL- 6 AR and low baseline MTACer were independent risk factors for increasing peritoneal solute transport rate (P 〈 0.05). Conclusion Intra- peritoneal inflammation significantly affects the alteration of PSTRs, and the dialysate IL-6 may be a predictor for increased PSTRs in PD patients.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2013年第9期645-649,共5页 Chinese Journal of Nephrology
基金 上海市科委资助项目(07QA14040,08dz1900500,114119a5900)
关键词 炎症 白细胞介素6 腹膜透析 Inflammation Interleukin-6 Peritoneal dialysis
  • 相关文献

参考文献2

二级参考文献32

  • 1Williams JD, Craig KJ, Topley N, et al. Peritoneal dialysis: chan- ges to the structure of the peritoneal membrane and potential for biocompatible solutions[ J ]. Kidney Int Suppl, 2003, 84 : S158 - S161.
  • 2Fusshoeller A. Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis[J]. Pediatr Nephrol, 2008, 23( 1 ) : 19 -25.
  • 3Davies SJ. Longitudinal relationship between solute transport and uhrafihration capacity in peritoneal dialysis patients [J]. Kidney Int, 2004, 66 (6) : 2437 - 2445.
  • 4Rumpsfeld M, McDonald SP,Johnson DW. Higher peritoneal trans- port status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient popula- tions[J]. JAm Soc Nephrol, 2006, 17(1): 271 -278.
  • 5Brimble KS, Walker M, Margetts PJ, et al. Meta-analysis: perito- neal membrane transport, mortality, and technique failure in perito- neal dialysis[J]. J Am Soc Nephrol, 2006, 17(9) : 2591 -2598.
  • 6Lai KN, Lai KB, Lam CW, et al. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis[ J]. Am J Kidney Dis, 2000, 35 (4): 644- 652.
  • 7Fiedler U, Augustin HG. Angiopoietins: a link between angiogene- sis and inflammation [ J ]. Trends Immunol, 2006, 27 (12) : 552 - 558.
  • 8Twardowski ZJ. PET - a simple approach for determining prescrip- tion for adequate dialysis therapy[ J]. Adv Perit Dial, 1990, 6: 186 - 191.
  • 9Pecoits-Filho R, Ara6jo MR, Lindholm B,et al. Plasma and dialy- sate IL-6 and VEGF concentrations are associated with high perito- neal solute transport rate [ J ]. Nephrol Dial Transplant, 2002, 17 (8) : 1480 -1486.
  • 10Pecoits-Filho R, Carvalho M J, Stenvinkel P, et al. Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis[J]. Perit DialInt, 2006, 26(1): 53-63.

共引文献8

同被引文献103

引证文献9

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部